Qualigen Therapeutics Inc. buy elfe
Start price
30.03.17
/
50%
€3,608.0
Target price
27.04.17
€7,892.5
Performance (%)
-47.50%
End price
27.04.17
€1,894.2
Summary
This prediction ended on 27.04.17 with a price of €1,894.2. Massive losses of -47.50% were the result for the BUY prediction by elfe. elfe has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Qualigen Therapeutics Inc. | -2.525% | -2.525% | -82.163% | -98.713% |
| iShares Core DAX® | 0.393% | -2.618% | 11.310% | 10.727% |
| iShares Nasdaq 100 | 0.394% | -10.309% | 23.697% | 33.228% |
| iShares Nikkei 225® | 1.038% | -8.365% | 7.878% | 1.931% |
| iShares S&P 500 | -0.046% | -4.991% | 21.704% | 34.810% |
Comments by elfe for this prediction
In the thread Ritter Pharmaceuticals Inc diskutieren
hartmut.kaiser.790 stimmt dem Crowdsentiment von 'Buy' zu
hartmut.kaiser.790 stimmt am 30.03.2017 dem Buy-Crowdsentiment mit dem Kursziel 3.5$ zu.
(Vom Mitglied beendet)